Long-term statins administration exacerbates diabetic nephropathy via ectopic fat deposition in diabetic mice
- PMID: 36693830
- PMCID: PMC9873739
- DOI: 10.1038/s41467-023-35944-z
Long-term statins administration exacerbates diabetic nephropathy via ectopic fat deposition in diabetic mice
Abstract
Statins play an important role in the treatment of diabetic nephropathy. Increasing attention has been given to the relationship between statins and insulin resistance, but many randomized controlled trials confirm that the therapeutic effects of statins on diabetic nephropathy are more beneficial than harmful. However, further confirmation of whether the beneficial effects of chronic statin administration on diabetic nephropathy outweigh the detrimental effects is urgently needed. Here, we find that long-term statin administration may increase insulin resistance, interfere with lipid metabolism, leads to inflammation and fibrosis, and ultimately fuel diabetic nephropathy progression in diabetic mice. Mechanistically, activation of insulin-regulated phosphatidylinositol 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway leads to increased fatty acid synthesis. Furthermore, statins administration increases lipid uptake and inhibits fatty acid oxidation, leading to lipid deposition. Here we show that long-term statins administration exacerbates diabetic nephropathy via ectopic fat deposition in diabetic mice.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
Comment in
-
The effect of long-term statin use on diabetic nephropathy.Nat Rev Endocrinol. 2023 Apr;19(4):189. doi: 10.1038/s41574-023-00813-8. Nat Rev Endocrinol. 2023. PMID: 36765197 No abstract available.
References
-
- Zhang L, et al. Trends in chronic kidney disease in China. N. Engl. J. Med. 2016;375:905–906. - PubMed
-
- McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes. 2002;51:7–18. - PubMed
-
- Chen X, et al. Disulfide-bond A oxidoreductase-like protein protects against ectopic fat deposition and lipid-related kidney damage in diabetic nephropathy. Kidney Int. 2019;95:880–895. - PubMed
-
- DeFronzo RA, Reeves WB, Awad AS. Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors. Nat. Rev. Nephrol. 2021;17:319–334. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
